Skip to main content

. 1960 Aug 20;2(5198):568–571. doi: 10.1136/bmj.2.5198.568

Argentaffinoma of the Lung with Carcinoid Syndrome

Maurice Joseph, R R Taylor

PMCID: PMC2097346 PMID: 14407943

568

Images in this article

Fig. 1
on p.569

Fig. 2
on p.569

Fig. 3
on p.570

Fig. 2
on p.571

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ERSPAMER V., ASERO B. Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature. 1952 May 10;169(4306):800–801. doi: 10.1038/169800b0. [DOI] [PubMed] [Google Scholar]
GOBLE A. J., HAY D. R., SANDLER M. 5-Hydroxytryptamine metabolism in acquired heart-disease associated with argentaffin carcinoma. Lancet. 1955 Nov 12;269(6898):1016–1017. doi: 10.1016/s0140-6736(55)93436-x. [DOI] [PubMed] [Google Scholar]
HAVERBACK B. J., SJOERDSMA A., TERRY L. L. Urinary excretion of the serotonin metabolite, 5-hydroxyindoleacetic acid, in various clinical conditions. N Engl J Med. 1956 Aug 9;255(6):270–272. doi: 10.1056/NEJM195608092550605. [DOI] [PubMed] [Google Scholar]
ISLER P., HEDINGER C. Metastasierendes Dünndarmcarcinoid mit schweren, vorwiegend das rechte Herz betreffenden Klappen-fehlern und Pulmonalstenose; ein eigenartiger Symptomenkomplex? Schweiz Med Wochenschr. 1953 Jan 3;83(1):4–7. [PubMed] [Google Scholar]
MACDONALD R. A. A study of 356 carcinoids of the gastrointestinal tract; report of four new cases of the carcinoid syndrome. Am J Med. 1956 Dec;21(6):867–878. doi: 10.1016/0002-9343(56)90101-2. [DOI] [PubMed] [Google Scholar]
MOHLER D. N. Evaluation of the urine test for serotonin metabolites. J Am Med Assoc. 1957 Mar 30;163(13):1138–1138. doi: 10.1001/jama.1957.82970480004008a. [DOI] [PubMed] [Google Scholar]
SANDLER M., SNOW P. J. An atypical carcinoid tumour secreting 5-hydroxytryptophan. Lancet. 1958 Jan 18;1(7012):137–139. doi: 10.1016/s0140-6736(58)90616-0. [DOI] [PubMed] [Google Scholar]
SCHNECKLOTH R. E., McISAAC W. M., PAGE I. H. Serotonin metabolism in carcinoid syndrome with metastatic bronchial adenoma. J Am Med Assoc. 1959 Jul 4;170(10):1143–1147. doi: 10.1001/jama.1959.03010100005003. [DOI] [PubMed] [Google Scholar]
STANFORD W. R., DAVIS J. E., GUNTER J. U., HOBART S. G., Jr Bronchial adenoma (carcinoid type) with solitary metastasis and associated functioning carcinoid syndrome. South Med J. 1958 Apr;51(4):449–454. doi: 10.1097/00007611-195804000-00008. [DOI] [PubMed] [Google Scholar]
THORSON A., BIORCK G., BJORKMAN G., WALDENSTROM J. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome. Am Heart J. 1954 Jun;47(5):795–817. doi: 10.1016/0002-8703(54)90152-0. [DOI] [PubMed] [Google Scholar]
THORSON A., NORDENFELT O. Development of valvular lesions in metastatic carcinoid disease. Br Heart J. 1959 Apr;21(2):243–248. doi: 10.1136/hrt.21.2.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
WARNER R. R. P., SOUTHREN A. L. Carcinoid syndrome produced by metastasizing bronchial adenoma. Am J Med. 1958 Jun;24(6):903–914. doi: 10.1016/0002-9343(58)90343-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES